United PPE America has received a CE mark certification for its CRISPR SARS-CoV-2 test kit which uses genetic engineering technology licensed from Cambridge, Mass.-based Sherlock Biosciences.

The test has specificity and sensitivity on par with conventional polymerase chain reaction (PCR) testing methods and a turnaround time from sample to read-out of less than one hour, according to United PPE.

Sherlock Biosciences CEO, Bryan Dechairo, said the company’s CRISPR diagnostic technology can enable increased access to diagnostics globally.